- The Wall Street Journal•3 days ago
After trading briefly higher in its debut as a public company, gene-editing startup Crispr Therapeutics AG saw its shares end barely above their initial public offering price in a fresh sign of tepid conditions ...
- Market Realist•3 days ago
Alexion Pharmaceuticals (ALXN) will announce its 3Q16 earnings on October 27, 2016. About 72.7% of the analysts covering the stock recommended a "buy."
Vertex Pharmaceuticals Incorporated (VRTX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||76.12 x 100|
|Ask||82.00 x 100|
|Day's Range||80.69 - 82.60|
|52wk Range||75.90 - 134.71|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-71.22|
|Avg Vol (3m)||1,402,390|
|Dividend & Yield||N/A (N/A)|